C vs RNXT · P/E 16, rev $85.22B vs rev $266.0K
Citigroup Inc. (C) versus RenovoRx Inc (RNXT) — a side-by-side from cached financials, not a winner call.
Citigroup Inc. (C) is a banks - diversified company listed on US.
RenovoRx Inc (RNXT) is a biotechnology company listed on US.
Latest reported C revenue for 2025-12-31 was $85.22B. Net income was $14.31B. Revenue was up 5.0% from 2024-12-31 to 2025-12-31. C currently screens at market cap $214.73B and trailing P/E 15.5.
Latest reported RNXT revenue for 2025-09-30 was $266.0K. Net income was -$2.9M. Revenue was down 37.0% from 2025-06-30 to 2025-09-30. RNXT currently screens at market cap $47.0M.
C currently screens at market cap $214.73B and trailing P/E 15.5. RNXT currently screens at market cap $47.0M.
Not investment advice. Open the C and RNXT stock pages for the full models.
Not investment advice.